Schizophrenia
Latest News
FDA Sets Goal Date for Antipsychotic Drug Bysanti
By Logan Lutton
May 6th 2025
The FDA has accepted the new drug application for the antipsychotic Bysanti and set a goal date for February 21, 2026.
May 6th 2025
The FDA has accepted the new drug application for the antipsychotic Bysanti and set a goal date for February 21, 2026.
